Mglur2 (Grm2) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neurons expressing metabotropic glutamate receptor 2 (mGluR2), also known as GRM2, are a critical component of the glutamatergic system in the brain. mGluR2 belongs to Group II metabotropic glutamate receptors (along with mGluR3/GRM3), which are primarily located on presynaptic terminals and regulate neurotransmitter release [1]. These neurons play essential roles in modulating excitatory transmission, anxiety regulation, neuroprotection, and various cognitive processes. The mGluR2 system has emerged as an important therapeutic target for neurological and psychiatric disorders.
The GRM2 gene is located on chromosome 7q21.12 in humans and encodes a 872-amino acid protein [2]. mGluR2 is a class C G-protein coupled receptor with distinct structural features:
Receptor Structure:
mGluR2 belongs to Group II mGluRs:
mGluR2 activates Gi/o protein signaling:
mGluR2-expressing neurons are found throughout the CNS:
| Brain Region | Expression Level | Function |
|---|---|---|
| Cortex | High | Modulation of excitation |
| Hippocampus | High | Memory, learning |
| Amygdala | High | Anxiety regulation |
| Basal Ganglia | Moderate | Motor control |
| Thalamus | Moderate | Sensory processing |
| Cerebellum | Low | Motor learning |
mGluR2 is predominantly presynaptic:
mGluR2 is an autoreceptor that regulates glutamate release:
Negative Feedback:
Modulation:
mGluR2 in the amygdala regulates anxiety:
Anxiolytic Effects:
Mechanisms:
mGluR2 activation can be neuroprotective:
In the hippocampus:
mGluR2 is a potential therapeutic target in Alzheimer's disease:
Dysregulation:
Therapeutic Potential:
mGluR2 is strongly implicated in schizophrenia:
Evidence:
Therapeutic Development:
In Parkinson's disease:
mGluR2 may be affected in ALS:
Clinical Candidates:
Mechanism:
Development:
Potential Uses:
Glutamatergic Signaling
Excitotoxicity
Synaptic Transmission Neuroprotection
GRM2 Gene - Glutamate Metabotropic Receptor 2 gene
Glutamate Receptors - Overview of glutamate receptor families
Metabotropic Glutamate Receptors - Group I, II, III mGluRs
GABAergic Signaling - Rel- Synaptic Transmissionsmission
Synaptic Transmission Overview of synaptic signaling
Excitotoxicity - Pathological glutamate signaling
The study of Mglur2 (Grm2) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Niswender, C.M., & Conn, P.J. (2010). Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annual Review of Pharmacology and Toxicology, 50, 295-322. 2010. ↩︎
Linden, A.M., et al. (2005). Anxiolytic-like action of the mGluR2/3 agonist LY379268. Neuropharmacology, 49(S1), 220. 2005. ↩︎
Dwyer, J.M., et al. (2012). Group II metabotropic glutamate receptors in Alzheimer's disease. Neuropharmacology, 62(5-6), 2128-2137. 2012. ↩︎